Impressive Q2 Performance Drives Further Guidance Raise At ANI

Firm Now Anticipates 2023 Net Revenue Between $425m And $445m

 
• By Chloe Kent

Management at ANI has upped its estimates for the second time this year after another impressive quarter, driven by Cortrophin gel and a strong generics performance.

Vector of a businessman blowing a horn shaped like a dollar sign
ANI's performance was driven by generic products and Cortrophin gel • Source: Shutterstock

More from Earnings

More from Business